Personal information

No personal information available

Activities

Collapse all

Works (4)

The emerging field of viroimmunotherapy for pediatric brain tumors

Neuro-Oncology
2024-11-04 | Journal article
DOI: 10.1093/neuonc/noae160
Contributors: Marc Garcia-Moure; Virginia Laspidea; Sumit Gupta; Andrew G Gillard; Soumen Khatua; Akhila Parthasarathy; Jiasen He; Frederick F Lang; Juan Fueyo; Marta M Alonso et al.
Source: check_circle
Crossref

Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models

JCI Insight
2024-09-24 | Journal article
DOI: 10.1172/jci.insight.175257
Contributors: Iker Ausejo-Mauleon; Naiara Martinez-Velez; Andrea Lacalle; Daniel de la Nava; Javier Cebollero; Helena Villanueva; Noelia Casares; Javier Marco-Sanz; Virginia Laspidea; Oren Becher et al.
Source: check_circle
Crossref

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

Neuro-Oncology
2024-08-05 | Journal article
DOI: 10.1093/neuonc/noae066
Contributors: Daniel de la Nava; Iker Ausejo-Mauleon; Virginia Laspidea; Marisol Gonzalez-Huarriz; Andrea Lacalle; Noelia Casares; Marta Zalacain; Lucía Marrodan; Marc García-Moure; Maria C Ochoa et al.
Source: check_circle
Crossref

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

JCI Insight
2022-04-08 | Journal article
DOI: 10.1172/jci.insight.154812
Contributors: Virginia Laspidea; Montserrat Puigdelloses; Sara Labiano; Lucía Marrodán; Marc Garcia-Moure; Marta Zalacain; Marisol Gonzalez-Huarriz; Naiara Martínez-Vélez; Iker Ausejo-Mauleon; Daniel de la Nava et al.
Source: check_circle
Crossref
How many people are using ORCID?